PREPARED-1 Trademark

Trademark Overview

On Thursday, October 12, 2023, a trademark application was filed for PREPARED-1 with the United States Patent and Trademark Office. The USPTO has given the PREPARED-1 trademark a serial number of 98220255. The federal status of this trademark filing is SU - FINAL REFUSAL - MAILED as of Wednesday, January 15, 2025. This trademark is owned by Eli Lilly and Company. The PREPARED-1 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of autoimmune diseases and perennial allergic rhinitis
prepared-1

General Information

Serial Number98220255
Word MarkPREPARED-1
Filing DateThursday, October 12, 2023
Status809 - SU - FINAL REFUSAL - MAILED
Status DateWednesday, January 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements

Pseudo MarkPREPARED ONE
Goods and ServicesMedical and scientific research in the field of autoimmune diseases and perennial allergic rhinitis

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 16, 2023
Primary Code042
First Use Anywhere DateFriday, April 26, 2024
First Use In Commerce DateFriday, April 26, 2024

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Monday, October 16, 2023NEW APPLICATION ENTERED
Monday, October 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 3, 2024ASSIGNED TO EXAMINER
Tuesday, May 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2024USE AMENDMENT FILED
Tuesday, August 6, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 6, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, October 9, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 9, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 13, 2024ASSIGNED TO EXAMINER
Thursday, November 14, 2024SU - NON-FINAL ACTION - WRITTEN
Thursday, November 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 14, 2024NON-FINAL ACTION E-MAILED
Friday, December 13, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 14, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 14, 2025ASSIGNED TO LIE
Wednesday, January 15, 2025SU - FINAL REFUSAL - WRITTEN
Wednesday, January 15, 2025FINAL REFUSAL E-MAILED
Wednesday, January 15, 2025NOTIFICATION OF FINAL REFUSAL EMAILED

Related Keywords

prepared perennial allergic rhinitis diseases autoimmune scientific research field medical